Journal for ImmunoTherapy of Cancer (Nov 2023)
1499 Molecular and immune profiling of lobular-enriched versus non-lobular invasive breast cancers
- Sarabjot Pabla,
- Marcia Eisenberg,
- Shengle Zhang,
- Shakti Ramkissoon,
- Kamal S Saini,
- Mary K Nesline,
- Jeffrey M Conroy,
- Kyle C Strickland,
- Heidi Ko,
- Rebecca A Previs,
- Zachary D Wallen,
- Jennifer B Jackson,
- Taylor J Jensen,
- Brian Caveney,
- Prasanth Reddy,
- Eric A Severson
Affiliations
- Sarabjot Pabla
- Aff4 OmniSeq Inc. 14203 Buffalo NY USA
- Marcia Eisenberg
- Aff13 0000 0004 0550 1859grid.419316.8Laboratory Corporation of America Holdings 27215 Burlington NC USA
- Shengle Zhang
- 3OmniSeq (Labcorp Oncology), Buffalo, NY, USA
- Shakti Ramkissoon
- R&D, Foundation Medicine Inc, Cambridge, Massachusetts, USA
- Kamal S Saini
- Labcorp Drug Development Inc, Princeton, New Jersey, USA
- Mary K Nesline
- 1Labcorp Oncology, Durham, NC, USA
- Jeffrey M Conroy
- OmniSeq Inc, Buffalo, New York, USA
- Kyle C Strickland
- 1Labcorp Oncology, Durham, NC, USA
- Heidi Ko
- 1Labcorp Oncology, Durham, NC, USA
- Rebecca A Previs
- 1Labcorp Oncology, Durham, NC, USA
- Zachary D Wallen
- 1Labcorp Oncology, Durham, NC, USA
- Jennifer B Jackson
- 4Personal Genome Diagnostics, Labcorp Oncology, Baltimore, MD, USA
- Taylor J Jensen
- 1Labcorp Oncology, Durham, NC, USA
- Brian Caveney
- 6Labcorp, Burlington, NC, USA
- Prasanth Reddy
- 6Labcorp, Burlington, NC, USA
- Eric A Severson
- 1Labcorp Oncology, Durham, NC, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.1499
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.
